Improvement of Clopidogrel Hypo-Responsiveness by Cilostazol Addition to the Dual Antiplatelet Therapy in PCI Patients Carrying CYP2C19 Gene Polymorphism

被引：0
|
作者：
Tanigawa, Takashi [1 ]
Nakata, Tomoyuki [1 ]
Ito, Masaaki [1 ]
Nishikawa, Masakatsu [1 ]
机构：
[1] Mie Univ Hosp, Tsu, Mie, Japan
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Antiplatelet drugs; Platelet receptor blockers; Intervention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14257
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Aiming for precision: CYP2C19 gene polymorphism and clopidogrel resistance in patients with peripheral artery disease
    Rashedi, Sina
    Sadeghipour, Parham
    Lou, Junyang
    THROMBOSIS RESEARCH, 2024, 236 : 240 - 241
  • [22] Dual P2Y12 and CYP2C19 gene polymorphism as a better marker of clopidogrel resistence
    Malek, L. A.
    Kisiel, B.
    Spiewak, M.
    Filipiak, K. J.
    Grabowski, M.
    Kostrzewa, G.
    Ploski, R.
    Opolski, G.
    EUROPEAN HEART JOURNAL, 2007, 28 : 126 - 127
  • [23] CYP2C19 polymorphism in Korean patients on warfarin therapy
    Lee, Sukhyang
    Hwang, Hyun Jin
    Kim, Jae-Moon
    Chung, Chin-Sang
    Kim, Jeong Hee
    ARCHIVES OF PHARMACAL RESEARCH, 2007, 30 (03) : 344 - 349
  • [24] CYP2C19 Polymorphism in Korean patients on warfarin therapy
    Sukhyang Lee
    Hyun Jin Hwang
    Jae-Moon Kim
    Chin-Sang Chung
    Jeong Hee Kim
    Archives of Pharmacal Research, 2007, 30
  • [25] Association between CYP2C19 genotype and the additional effect of cilostazol to clopidogrel resistance in neuroendovascular therapy
    Tajima, Hayato
    Izumi, Takashi
    Miyachi, Shigeru
    Matsubara, Noriaki
    Ito, Masashi
    Imai, Tasuku
    Nishihori, Masahiro
    Shintai, Kazunori
    Okamoto, Sho
    Araki, Yoshio
    Kumakura, Yasuo
    Furukawa-Hibi, Yoko
    Yamada, Kiyofumi
    Wakabayashi, Toshihiko
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2018, 80 (02): : 207 - 215
  • [26] Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects
    Fontana, P.
    Hulot, J.-S.
    De Moerloose, P.
    Gaussem, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (10) : 2153 - 2155
  • [27] The relative contribution of the CYP2C19*2 polymorphism in the low responsiveness to clopidogrel in the VASP02 study
    Aleil, B.
    Jacquemin, L.
    De Poli, F.
    Zaehringer, M.
    Collet, J. P.
    Montalescot, G.
    Leon, C.
    Cazenave, J. P.
    Dickele, M. C.
    Monassier, J. P.
    Gachet, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 104 - 104
  • [28] CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease
    Hoh, Brian L.
    Gong, Yan
    McDonough, Caitrin W.
    Waters, Michael F.
    Royster, Adrienne J.
    Sheehan, Tiffany O.
    Burkley, Ben
    Langaee, Taimour Y.
    Mocco, J.
    Zuckerman, Scott L.
    Mummareddy, Nishit
    Stephens, Marcus L., II
    Ingram, Christie
    Shaffer, Christian M.
    Denny, Joshua C.
    Brilliant, Murray H.
    Kitchner, Terrie E.
    Linneman, James G.
    Roden, Dan M.
    Johnson, Julie A.
    JOURNAL OF NEUROSURGERY, 2016, 124 (06) : 1746 - 1751
  • [29] CYP2C19 and CES1 Polymorphisms and Efficacy of Clopidogrel and Aspirin Dual Antiplatelet Therapy in Patients with Symptomatic Intracranial Atherosclerotic Disease
    Hoh, Brian L.
    Gong, Yan
    Waters, Michael
    Mocco, J.
    Zuckerman, Scott
    Ingram, Christie
    Shaffer, Christian
    Denny, Joshua
    Brilliant, Murray
    Kitchner, Terrie
    Linneman, James
    Roden, Dan
    Johnson, Julie
    JOURNAL OF NEUROSURGERY, 2015, 123 (02) : A504 - A504
  • [30] The relative contribution of the CYP2C19*2 polymorphism in the low responsiveness to clopidogrel in the VASP-02 study
    Aleil, B.
    De Poli, F.
    Zaehringer, M.
    Collet, J. P.
    Montalescot, G.
    Leon, C.
    Cazenave, J. P.
    Dickele, M. C.
    Monassier, J. P.
    Gachet, C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 327 - 328
12345